<VariationArchive RecordType="classified" VariationID="15929" VariationName="NM_000516.7(GNAS):c.725del (p.Thr242fs)" VariationType="Deletion" Accession="VCV000015929" Version="1" NumberOfSubmissions="3" NumberOfSubmitters="1" DateLastUpdated="2023-05-27" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30968" VariationID="15929">
      <GeneList>
        <Gene Symbol="GNAS" FullName="GNAS complex locus" GeneID="2778" HGNC_ID="HGNC:4392" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58839748" stop="58911192" display_start="58839748" display_stop="58911192" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57414794" stop="57486249" display_start="57414794" display_stop="57486249" Strand="+" />
          </Location>
          <OMIM>139320</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAS">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000516.7(GNAS):c.725del (p.Thr242fs)</Name>
      <CanonicalSPDI>NC_000020.11:58909689:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58909690" stop="58909690" display_start="58909690" display_stop="58909690" variantLength="1" positionVCF="58909689" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57484745" stop="57484745" display_start="57484745" display_stop="57484745" variantLength="1" positionVCF="57484744" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T243fs</ProteinChange>
      <ProteinChange>T183fs</ProteinChange>
      <ProteinChange>T227fs</ProteinChange>
      <ProteinChange>T242fs</ProteinChange>
      <ProteinChange>T228fs</ProteinChange>
      <ProteinChange>T885fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016194.2" sequenceAccession="NG_016194" sequenceVersion="2" change="g.74951del">
            <Expression>NG_016194.2:g.74951del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000516.7" sequenceAccession="NM_000516" sequenceVersion="7" change="c.725del" MANESelect="true">
            <Expression>NM_000516.7:c.725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000507.1" sequenceAccession="NP_000507" sequenceVersion="1" change="p.Thr242fs">
            <Expression>NP_000507.1:p.Thr242fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077488.5" sequenceAccession="NM_001077488" sequenceVersion="5" change="c.728del">
            <Expression>NM_001077488.5:c.728del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070956.1" sequenceAccession="NP_001070956" sequenceVersion="1" change="p.Thr243fs">
            <Expression>NP_001070956.1:p.Thr243fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077489.4" sequenceAccession="NM_001077489" sequenceVersion="4" change="c.680del">
            <Expression>NM_001077489.4:c.680del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070957.1" sequenceAccession="NP_001070957" sequenceVersion="1" change="p.Thr227fs">
            <Expression>NP_001070957.1:p.Thr227fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077490.3" sequenceAccession="NM_001077490" sequenceVersion="3" change="c.*586del">
            <Expression>NM_001077490.3:c.*586del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001309840.2" sequenceAccession="NM_001309840" sequenceVersion="2" change="c.548del">
            <Expression>NM_001309840.2:c.548del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001296769.1" sequenceAccession="NP_001296769" sequenceVersion="1" change="p.Thr183fs">
            <Expression>NP_001296769.1:p.Thr183fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001309861.2" sequenceAccession="NM_001309861" sequenceVersion="2" change="c.548del">
            <Expression>NM_001309861.2:c.548del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001296790.1" sequenceAccession="NP_001296790" sequenceVersion="1" change="p.Thr183fs">
            <Expression>NP_001296790.1:p.Thr183fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016592.5" sequenceAccession="NM_016592" sequenceVersion="5" change="c.*631del" MANEPlusClinical="true">
            <Expression>NM_016592.5:c.*631del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080425.4" sequenceAccession="NM_080425" sequenceVersion="4" change="c.2654del" MANEPlusClinical="true">
            <Expression>NM_080425.4:c.2654del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536350.2" sequenceAccession="NP_536350" sequenceVersion="2" change="p.Thr885fs">
            <Expression>NP_536350.2:p.Thr885fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080426.4" sequenceAccession="NM_080426" sequenceVersion="4" change="c.683del">
            <Expression>NM_080426.4:c.683del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536351.1" sequenceAccession="NP_536351" sequenceVersion="1" change="p.Thr228fs">
            <Expression>NP_536351.1:p.Thr228fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.57484745del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.57484745del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.58909690del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.58909690del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="139320.0003" DB="OMIM" />
        <XRef Type="rs" ID="1601163749" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000516.7(GNAS):c.725del (p.Thr242fs) AND Pseudopseudohypoparathyroidism" Accession="RCV000017282" Version="28">
        <ClassifiedConditionList TraitSetID="5180">
          <ClassifiedCondition DB="MedGen" ID="C0033835">Pseudopseudohypoparathyroidism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000516.7(GNAS):c.725del (p.Thr242fs) AND Progressive osseous heteroplasia" Accession="RCV000017283" Version="24">
        <ClassifiedConditionList TraitSetID="5181">
          <ClassifiedCondition DB="MedGen" ID="C0334041">Progressive osseous heteroplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000516.7(GNAS):c.725del (p.Thr242fs) AND Pseudohypoparathyroidism" Accession="RCV000017281" Version="27">
        <ClassifiedConditionList TraitSetID="5179">
          <ClassifiedCondition DB="MedGen" ID="C0033806">Pseudohypoparathyroidism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-07-15" NumberOfSubmissions="3" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18553568</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2122458</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5181" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5691" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osseus Heteroplasia, Progressive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive osseous heteroplasia</ElementValue>
                <XRef ID="Progressive+osseous+heteroplasia/5985" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008153" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ECTOPIC OSSIFICATION, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="166350" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">POH</ElementValue>
                <XRef Type="MIM" ID="166350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="109" />
                <XRef ID="109" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="2762" DB="Orphanet" />
              <XRef ID="C0334041" DB="MedGen" />
              <XRef ID="MONDO:0008153" DB="MONDO" />
              <XRef Type="MIM" ID="166350" DB="OMIM" />
              <XRef Type="primary" ID="HP:0025027" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5179" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3403" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pseudohypoparathyroidism</ElementValue>
                <XRef ID="HP:0000852" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019992" DB="MONDO" />
                <XRef ID="58976002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHP1A</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="79443" DB="Orphanet" />
              <XRef ID="97593" DB="Orphanet" />
              <XRef ID="C0033806" DB="MedGen" />
              <XRef ID="MONDO:0019992" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000852" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5180" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4060" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pseudopseudohypoparathyroidism</ElementValue>
                <XRef ID="Pseudopseudohypoparathyroidism/6049" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012912" DB="MONDO" />
                <XRef ID="237659007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albright hereditary osteodystrophy without multiple hormone resistance</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPHP</ElementValue>
                <XRef Type="MIM" ID="612463" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7860" />
                <XRef ID="7860" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="79445" DB="Orphanet" />
              <XRef ID="C0033835" DB="MedGen" />
              <XRef ID="MONDO:0012912" DB="MONDO" />
              <XRef Type="MIM" ID="612463" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37553" SubmissionDate="2016-08-05" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="139320.0003_PSEUDOHYPOPARATHYROIDISM, TYPE IA" title="GNAS, 1-BP DEL, 725C_PSEUDOHYPOPARATHYROIDISM, TYPE IA" />
        <ClinVarAccession Accession="SCV000037553" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a mother with PPHP (612463) and her daughter with PHP1A (103580), Weinstein et al. (1990) identified a heterozygous 1-bp deletion (G) in exon 10 of the GNAS gene, resulting in a frameshift.</Attribute>
              <Citation>
                <ID Source="PubMed">2122458</ID>
              </Citation>
              <XRef DB="OMIM" ID="612463" Type="MIM" />
              <XRef DB="OMIM" ID="103580" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Adegbite et al. (2008) identified the same deletion (725delC) in an unaffected carrier father and in 3 of his 5 children with progressive osseous heteroplasia (POH; 166350). The 3 children exhibited varying degrees of severity based on the extent of the heterotropic ossification lesions and resultant functional impairment.</Attribute>
              <Citation>
                <ID Source="PubMed">18553568</ID>
              </Citation>
              <XRef DB="OMIM" ID="166350" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNAS" />
          </GeneList>
          <Name>GNAS, 1-BP DEL, 725C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 725C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="139320.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PSEUDOHYPOPARATHYROIDISM, TYPE IA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37554" SubmissionDate="2016-08-05" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="139320.0003_PSEUDOPSEUDOHYPOPARATHYROIDISM" title="GNAS, 1-BP DEL, 725C_PSEUDOPSEUDOHYPOPARATHYROIDISM" />
        <ClinVarAccession Accession="SCV000037554" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a mother with PPHP (612463) and her daughter with PHP1A (103580), Weinstein et al. (1990) identified a heterozygous 1-bp deletion (G) in exon 10 of the GNAS gene, resulting in a frameshift.</Attribute>
              <Citation>
                <ID Source="PubMed">2122458</ID>
              </Citation>
              <XRef DB="OMIM" ID="612463" Type="MIM" />
              <XRef DB="OMIM" ID="103580" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Adegbite et al. (2008) identified the same deletion (725delC) in an unaffected carrier father and in 3 of his 5 children with progressive osseous heteroplasia (POH; 166350). The 3 children exhibited varying degrees of severity based on the extent of the heterotropic ossification lesions and resultant functional impairment.</Attribute>
              <Citation>
                <ID Source="PubMed">18553568</ID>
              </Citation>
              <XRef DB="OMIM" ID="166350" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNAS" />
          </GeneList>
          <Name>GNAS, 1-BP DEL, 725C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 725C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="139320.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">PSEUDOPSEUDOHYPOPARATHYROIDISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37555" SubmissionDate="2016-08-05" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="139320.0003_OSSEOUS HETEROPLASIA, PROGRESSIVE" title="GNAS, 1-BP DEL, 725C_OSSEOUS HETEROPLASIA, PROGRESSIVE" />
        <ClinVarAccession Accession="SCV000037555" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a mother with PPHP (612463) and her daughter with PHP1A (103580), Weinstein et al. (1990) identified a heterozygous 1-bp deletion (G) in exon 10 of the GNAS gene, resulting in a frameshift.</Attribute>
              <Citation>
                <ID Source="PubMed">2122458</ID>
              </Citation>
              <XRef DB="OMIM" ID="612463" Type="MIM" />
              <XRef DB="OMIM" ID="103580" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Adegbite et al. (2008) identified the same deletion (725delC) in an unaffected carrier father and in 3 of his 5 children with progressive osseous heteroplasia (POH; 166350). The 3 children exhibited varying degrees of severity based on the extent of the heterotropic ossification lesions and resultant functional impairment.</Attribute>
              <Citation>
                <ID Source="PubMed">18553568</ID>
              </Citation>
              <XRef DB="OMIM" ID="166350" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNAS" />
          </GeneList>
          <Name>GNAS, 1-BP DEL, 725C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 725C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="139320.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">OSSEOUS HETEROPLASIA, PROGRESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37554" TraitType="Disease" MappingType="Name" MappingValue="PSEUDOPSEUDOHYPOPARATHYROIDISM" MappingRef="Alternate">
        <MedGen CUI="C0033835" Name="Pseudopseudohypoparathyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37555" TraitType="Disease" MappingType="Name" MappingValue="OSSEOUS HETEROPLASIA, PROGRESSIVE" MappingRef="Alternate">
        <MedGen CUI="C0334041" Name="Progressive osseous heteroplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37553" TraitType="Disease" MappingType="Name" MappingValue="PSEUDOHYPOPARATHYROIDISM, TYPE IA" MappingRef="Preferred">
        <MedGen CUI="C3494506" Name="Pseudohypoparathyroidism type I A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

